longbridge

AC Immune

ACIU
----

All Shareholders

Shareholder Type

  • Public and others34.68%
  • VC/PE firms28.48%
  • Hedge funds19.94%
  • Private companies6.47%
  • Others10.44%

Major Shareholders

Major Shareholders Latest
Shareholder
BVF Partners L.P.
19.94%19.82M0.05%+0
dievini Hopp BioTech holding GmbH & Co. KG
16.41%16.32M0.04%+0
Varuma AG
12.07%12.00M0.03%+0
AFFiRiS AG
6.47%6.43M0.01%+0
Andrea PfeiferFormer Co-Founder, CEO & Director
3.86%3.83M0.03%-20.00K
Wells Fargo & Company
1.01%1.00M<0.01%-243.00
Renaissance Technologies LLC
0.84%840.13K0.22%+215.76K
Millennium Management LLC
0.78%773.59K0.02%-19.06K
Friedrich von Bohlen und HalbachFormer Independent Non-Executive Director
0.69%687.13K<0.01%+0
BlackRock, Inc.
0.52%519.27K<0.01%-5.00K
Christof HettichFormer Director
0.47%470.78K<0.01%+0
Mathias HothumFormer Non-Executive Director
0.36%360.82K<0.01%+0
Dimensional Fund Advisors LP
0.34%340.08K0.05%-50.08K
Arrowstreet Capital, Limited Partnership
0.23%232.95K0.17%-172.71K
Citadel Advisors LLC
0.21%207.61K0.06%-59.63K
Piergiorgio DonatiChief Operating Officer
0.14%141.12K<0.01%+0
Morgan Stanley
0.13%131.40K0.04%+42.56K
Two Sigma Investments, LP
0.10%102.83K0.06%+63.73K
Qube Research & Technologies Ltd
0.09%92.35K--+92.35K
UBS Asset Management AG
0.09%85.61K0.02%-16.02K
© 2026 Longbridge｜Terms of ServicePrivacy Policy